6550--Blood Bank Reagents - New Base Plus Four Option Year Contract
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
245-NETWORK CONTRACT OFFICE 5 (36C245)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C24526Q0650
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents4
The Department of Veterans Affairs, through its 245-Network Contract Office 5, has issued a Combined Synopsis/Solicitation (Procurement Identifier: 36C24526Q0650) for the procurement of Blood Bank Reagents. This requirement is structured as a new base contract with four option years, reflecting the agency’s intent to secure a reliable, long-term supply of in-vitro diagnostic substances essential for blood bank operations at its Huntington, West Virginia facility.
The primary objective of this procurement is to ensure the continuous availability of high-quality blood bank reagents, which are critical for the safe and effective testing, processing, and management of blood products within the VA healthcare system. The scope of the contract encompasses the supply and delivery of these reagents, with specific line items and requirements detailed in the attached Combined Synopsis Solicitation document referenced in the notice. The procurement falls under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing), with Product Service Code 6550, indicating a focus on laboratory reagents and test kits.
Key deliverables include the timely provision of blood bank reagents that meet all applicable regulatory and quality standards, supporting the clinical laboratory’s mission to provide accurate and reliable diagnostic services to veterans. The contract is designed to accommodate evolving needs over the base period and four option years, ensuring flexibility and continuity of service.
The solicitation has been amended to update line items and clarify language, and interested vendors are directed to review the revised RFQ (Request for Quotation) documentation for comprehensive details on technical specifications, quantities, and submission requirements. All responses must be submitted via email to the primary point of contact, Zachary K Altner, at [email protected], by 10:00 A.M. EST on August 17, 2026. Mr. Altner can also be reached at (410) 642-2411 ext 25262 for further inquiries.
This opportunity is classified as a federal procurement and is currently active. Contractors with capabilities in the manufacturing and supply of in-vitro diagnostic substances, particularly those with experience serving healthcare or government clients, are encouraged to review the solicitation documents and consider submitting a response. The place of performance is Huntington, West Virginia, and all contractual obligations will be governed by the terms set forth by the Department of Veterans Affairs.
For additional information, including access to the solicitation attachments and any amendments, interested parties should refer to the official notice on SAM.gov (Opportunity ID: 7273d9b1d4a1490c8f3aa6b139dfd05c).
This procurement represents a significant opportunity for qualified vendors to support the VA’s mission of delivering high-quality healthcare services to veterans through the provision of essential laboratory reagents.